nicardipine has been researched along with iberiotoxin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motohashi, O; Sugai, K; Suzuki, M; Yanagisawa, T; Yoshimoto, T | 1 |
| Beech, DJ; Prior, HM; Yates, MS | 1 |
| Isaacson, JS; Murphy, GJ | 1 |
| Bayguinov, O; Hagen, B; Sanders, KM | 1 |
| Asano, S; Bender, SB; Borbouse, L; Bratz, IN; Dick, GM; Dincer, UD; Neeb, ZP; Payne, GA; Sturek, M; Tune, JD | 1 |
5 other study(ies) available for nicardipine and iberiotoxin
| Article | Year |
|---|---|
Levcromakalim decreases vascular tone, cytoplasmic Ca2+ and Ca2+ sensitivity in canine basilar artery.
Topics: Animals; Basilar Artery; Calcium; Calcium Channel Blockers; Cromakalim; Cytoplasm; Dogs; Dose-Response Relationship, Drug; Female; Glyburide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Peptides; Potassium Channel Blockers; Potassium Channels; Serotonin; Tetraethylammonium; Vasoconstriction | 1998 |
Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.
Topics: 4-Aminopyridine; Adenosine; Amifampridine; Animals; Antihypertensive Agents; Apamin; Arteries; Barium; Cromakalim; Enzyme Inhibitors; Glyburide; In Vitro Techniques; Kidney; Male; Nicardipine; Ouabain; Peptides; Phenethylamines; Potassium; Potassium Channels; Pressure; Purinergic P1 Receptor Agonists; Rabbits; Receptor, Adenosine A2A; Receptors, Purinergic P1; Vasodilation; Vasodilator Agents | 1999 |
Glutamate-mediated extrasynaptic inhibition: direct coupling of NMDA receptors to Ca(2+)-activated K+ channels.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Evoked Potentials; Excitatory Postsynaptic Potentials; Glutamic Acid; Ion Channel Gating; Ion Transport; Large-Conductance Calcium-Activated Potassium Channels; Macromolecular Substances; Membrane Potentials; Models, Neurological; Nerve Tissue Proteins; Neuronal Plasticity; Nicardipine; Olfactory Bulb; Olfactory Receptor Neurons; omega-Conotoxin GVIA; omega-Conotoxins; Patch-Clamp Techniques; Peptides; Potassium; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Smell | 2001 |
Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes.
Topics: Animals; Calcium Signaling; Colon; Electric Conductivity; Imidazoles; Indoles; Male; Maleimides; Membrane Potentials; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Myocytes, Smooth Muscle; Neurokinin A; Nicardipine; Patch-Clamp Techniques; Peptide Fragments; Peptides; Physalaemin; Receptors, Tachykinin; Ryanodine; Ryanodine Receptor Calcium Release Channel; Second Messenger Systems; Substance P | 2003 |
Impaired function of coronary BK(Ca) channels in metabolic syndrome.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 2-Chloroadenosine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Coronary Circulation; Coronary Vessels; Diet, Atherogenic; Disease Models, Animal; Dose-Response Relationship, Drug; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channel beta Subunits; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Metabolic Syndrome; Microcirculation; Muscle, Smooth, Vascular; Mycotoxins; Nicardipine; Peptides; Phenotype; Potassium Channel Blockers; Swine; Swine, Miniature; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |